e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
New treatments for asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Growth factor treatment for asthma by restoration of epithelial barrier function
C. Xiao, V. Tear, S. Field, E. Vernon-Wilson, S. T. Holgate, S. M. Puddicombe, D. E. Davies, P. Monk (Southampton, United Kingdom)
Source:
Annual Congress 2008 - New treatments for asthma
Session:
New treatments for asthma
Session type:
Oral Presentation
Number:
3018
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Xiao, V. Tear, S. Field, E. Vernon-Wilson, S. T. Holgate, S. M. Puddicombe, D. E. Davies, P. Monk (Southampton, United Kingdom). Growth factor treatment for asthma by restoration of epithelial barrier function. Eur Respir J 2008; 32: Suppl. 52, 3018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats
Source: Eur Respir J 2007; 30: 31-39
Year: 2007
CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium
Source: Eur Respir J 2013; 42: 1553-1562
Year: 2013
Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor
Source: Eur Respir J 2008; 31: 714-724
Year: 2008
Hepatocyte growth factor prevents airway remodelling in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 194s
Year: 2003
Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo
Source: Eur Respir J 2011; 38: 939-946
Year: 2011
Inhibition of uPA-uPAR signaling restores respiratory epithelial barrier function in asthma and COPD
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 581s
Year: 2005
PP113 – Epidermal growth factor receptor in airway remodelling during allergic airway disease – divergent roles during early life and adulthood?
Source: ERS Lung Science Conference 2021
Year: 2021
Changes in epithelial barrier components E-cadherin, Beta-catenin, EGR with steroid treatment in murine model of asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Fibroblast growth factor 23 and Klotho contribute to airway inflammation
Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018
Year: 2018
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro
Source: Eur Respir J 2002; 20: 1449-1456
Year: 2002
High airway responsiveness as a risk factor for lung function decline
Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach
Year: 2010
Corticosteroids improve airway epithelial regeneration and restore oxidative stress-induced epithelial barrier dysfunction
Source: Annual Congress 2012 - New insights into airway epithelial cell physiology
Year: 2012
LSC - 2021 - Epidermal growth factor receptor in airway remodelling during allergic airway disease – divergent roles during early life and adulthood?
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Vascular endothelial growth factor (VEGF) , a specific marker of angiogenesis, is increased in asthmatic airways following allergen challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 227s
Year: 2004
Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma
Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma
Year: 2004
Intrinsic and environmental factors contribute to ciliary dysfunction of human airway epithelial cells in asthma
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept